awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35285011-1F8F9FB9-A2B7-46B7-B6E1-188C0DE425CC
Q35285011-1F8F9FB9-A2B7-46B7-B6E1-188C0DE425CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-1F8F9FB9-A2B7-46B7-B6E1-188C0DE425CC
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.
P2860
Q35285011-1F8F9FB9-A2B7-46B7-B6E1-188C0DE425CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-1F8F9FB9-A2B7-46B7-B6E1-188C0DE425CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ce860f9b629b2632ab831d84c0ac8ed697cb672
P2860
Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.